These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23619351)

  • 1. Bioactive volatile organic compounds from Antarctic (sponges) bacteria.
    Papaleo MC; Romoli R; Bartolucci G; Maida I; Perrin E; Fondi M; Orlandini V; Mengoni A; Emiliani G; Tutino ML; Parrilli E; de Pascale D; Michaud L; Lo Giudice A; Fani R
    N Biotechnol; 2013 Sep; 30(6):824-38. PubMed ID: 23619351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.
    Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R
    Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the volatile profile of Antarctic bacteria by using solid-phase microextraction-gas chromatography-mass spectrometry.
    Romoli R; Papaleo MC; de Pascale D; Tutino ML; Michaud L; LoGiudice A; Fani R; Bartolucci G
    J Mass Spectrom; 2011 Oct; 46(10):1051-9. PubMed ID: 22012672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of three sponge-associated Arthrobacter Antarctic strains, inhibiting the growth of Burkholderia cepacia complex bacteria by synthesizing volatile organic compounds.
    Orlandini V; Maida I; Fondi M; Perrin E; Papaleo MC; Bosi E; de Pascale D; Tutino ML; Michaud L; Lo Giudice A; Fani R
    Microbiol Res; 2014; 169(7-8):593-601. PubMed ID: 24231161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Draft genomes of three Antarctic Psychrobacter strains producing antimicrobial compounds against Burkholderia cepacia complex, opportunistic human pathogens.
    Fondi M; Orlandini V; Perrin E; Maida I; Bosi E; Papaleo MC; Michaud L; Lo Giudice A; de Pascale D; Tutino ML; Liò P; Fani R
    Mar Genomics; 2014 Feb; 13():37-8. PubMed ID: 24401162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary data on antibacterial activity of Echinacea purpurea-associated bacterial communities against Burkholderia cepacia complex strains, opportunistic pathogens of Cystic Fibrosis patients.
    Chiellini C; Maida I; Maggini V; Bosi E; Mocali S; Emiliani G; Perrin E; Firenzuoli F; Mengoni A; Fani R
    Microbiol Res; 2017 Mar; 196():34-43. PubMed ID: 28164789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
    Sannino F; Parrilli E; Apuzzo GA; de Pascale D; Tedesco P; Maida I; Perrin E; Fondi M; Fani R; Marino G; Tutino ML
    N Biotechnol; 2017 Mar; 35():13-18. PubMed ID: 27989956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of multiplex single nucleotide primer extension (mSNuPE) to the identification of bacteria: the Burkholderia cepacia complex case.
    Ferri L; Perrin E; Campana S; Tabacchioni S; Taccetti G; Cocchi P; Ravenni N; Dalmastri C; Chiarini L; Bevivino A; Manno G; Mentasti M; Fani R
    J Microbiol Methods; 2010 Mar; 80(3):251-6. PubMed ID: 20079386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic interactions between psychrotrophic cultivable bacteria isolated from Antarctic sponges: a preliminary analysis.
    Mangano S; Michaud L; Caruso C; Brilli M; Bruni V; Fani R; Lo Giudice A
    Res Microbiol; 2009; 160(1):27-37. PubMed ID: 19013518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Activity of Monoramnholipids Produced by Bacterial Strains Isolated from the Ross Sea (Antarctica).
    Tedesco P; Maida I; Palma Esposito F; Tortorella E; Subko K; Ezeofor CC; Zhang Y; Tabudravu J; Jaspars M; Fani R; de Pascale D
    Mar Drugs; 2016 Apr; 14(5):. PubMed ID: 27128927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Draft genome sequence of the volatile organic compound-producing Antarctic bacterium Arthrobacter sp. strain TB23, able to inhibit cystic fibrosis pathogens belonging to the Burkholderia cepacia complex.
    Fondi M; Orlandini V; Maida I; Perrin E; Papaleo MC; Emiliani G; de Pascale D; Parrilli E; Tutino ML; Michaud L; Lo Giudice A; Fani R
    J Bacteriol; 2012 Nov; 194(22):6334-5. PubMed ID: 23105071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence divergence in type III secretion gene clusters of the Burkholderia cepacia complex.
    Glendinning KJ; Parsons YN; Duangsonk K; Hales BA; Humphreys D; Hart CA; Winstanley C
    FEMS Microbiol Lett; 2004 Jun; 235(2):229-35. PubMed ID: 15183868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphasic characterisation of Burkholderia cepacia-like isolates leading to the emended description of Burkholderia pyrrocinia.
    Storms V; Van Den Vreken N; Coenye T; Mahenthiralingam E; LiPuma JJ; Gillis M; Vandamme P
    Syst Appl Microbiol; 2004 Sep; 27(5):517-26. PubMed ID: 15490552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology.
    Mahenthiralingam E; Baldwin A; Dowson CG
    J Appl Microbiol; 2008 Jun; 104(6):1539-51. PubMed ID: 18217926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Metataxonomic Approach Reveals Diversified Bacterial Communities in Antarctic Sponges.
    Ruocco N; Esposito R; Bertolino M; Zazo G; Sonnessa M; Andreani F; Coppola D; Giordano D; Nuzzo G; Lauritano C; Fontana A; Ianora A; Verde C; Costantini M
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33810171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex.
    Vanlaere E; Sergeant K; Dawyndt P; Kallow W; Erhard M; Sutton H; Dare D; Devreese B; Samyn B; Vandamme P
    J Microbiol Methods; 2008 Oct; 75(2):279-86. PubMed ID: 18627778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the gyrB gene to discriminate among species of the Burkholderia cepacia complex.
    Tabacchioni S; Ferri L; Manno G; Mentasti M; Cocchi P; Campana S; Ravenni N; Taccetti G; Dalmastri C; Chiarini L; Bevivino A; Fani R
    FEMS Microbiol Lett; 2008 Apr; 281(2):175-82. PubMed ID: 18312571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere.
    Peeters C; Zlosnik JE; Spilker T; Hird TJ; LiPuma JJ; Vandamme P
    Syst Appl Microbiol; 2013 Oct; 36(7):483-9. PubMed ID: 23867250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide of Burkholderia cepacia complex.
    Vinion-Dubiel AD; Goldberg JB
    J Endotoxin Res; 2003; 9(4):201-13. PubMed ID: 12935351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.